Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1349)	8/1/2005 4:04:02 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

CURE Is trading above the 2.50 level today after it announced that it has signed 12 "Wound Management Program" contracts with hospitals so far this year. These 12 hospitals are located in CA, GA,IN, KY,MO,NM,NC,OH and TX <g> The stock is up more than 15% today and volume has remained moderate at 305,858 bigcharts.marketwatch.com The 1st Q reults were not good since it had a loss of $0.10/shr vs. $0.24 in the black in 2004 in spite of better revenues that were up 32% to 86.7M CURE has a large LTD and although the stock traded as high as $14 last year, $19 in 2003 and $23 in 2002, I think it has to be approached with extra caution.<g> Bernard

To: Jibacoa who wrote (1349)	8/9/2005 12:24:56 PM
From: Jibacoa	Respond to of 3722

GORX Seems ready to resume its uptrend.<g> It has closed its August 3 upgap and today is up more than 14% on volume of 314,958, which it is still modest compared with the 2,995,302 on August 3.<g> bigcharts.marketwatch.com On the 1stQ (June) revenues were up 70% to 11.8M and earnings up 300% to $0.04/shr It probably should report good results, by comparison,on the 2nd & 3rd Qs when it had losses of $0.03/shr & $0.12/shr last year. AS previously mentioned. the company received FDA approval for Mucotrol in December in spite of the FDA "confusion".<g> The insiders reportedly hold more than 50% Bernard